Evidence map›Paper›PMID 28747493›Full record

ArticleJournal of virology2017

Role of Viral Hemorrhagic Septicemia Virus Matrix (M) Protein in Suppressing Host Transcription.

Qi Ke, Wade Weaver, Adam Pore, Bartolomeo Gorgoglione, Julia Halo Wildschutte, Peng Xiao, Brian S Shepherd, Allyn Spear, Krishnamurthy Malathi, Carol A Stepien and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Transcriptome Profiling ofMicroorganisms · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Evolutionary trajectory of fishEcology and evolution · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Qi KeDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Wade WeaverDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Adam PoreDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Bartolomeo GorgoglioneDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Julia Halo WildschutteDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Peng XiaoInstitute of Marine and Environmental Technology, University of Maryland Baltimore County, Baltimore, Maryland, USA.
Brian S ShepherdUSDA/ARS, School of Freshwater Sciences, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Allyn SpearUSDA/ARS, School of Freshwater Sciences, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Krishnamurthy MalathiDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA.
Carol A StepienNOAA Pacific Marine Environmental Laboratory (PMEL), Seattle, Washington, USA.
Vikram N VakhariaInstitute of Marine and Environmental Technology, University of Maryland Baltimore County, Baltimore, Maryland, USA.
Douglas W LeamanDepartment of Biological Sciences, The University of Toledo, Toledo, Ohio, USA douglas.leaman@wright.edu.
University of Toledo · USUniversity of Maryland, Baltimore County · USUniversity of Wisconsin–Milwaukee · USNOAA Pacific Marine Environmental Laboratory · US

Funding

Novel role of RNA signaling in cross-talk between autophagy and apoptosisR15AI119980 · NIAID · UNIVERSITY OF TOLEDO · PI KRISHNAMURTHY, MALATHI · 2016 to 2016
$443k
NIAID NIH HHS R15 AI119980
6 · The paper itself

Abstract

Viral hemorrhagic septicemia virus (VHSV) is a pathogenic fish rhabdovirus found in discrete locales throughout the Northern Hemisphere. VHSV infection of fish cells leads to upregulation of the host's virus detection response, but the virus quickly suppresses interferon (IFN) production and antiviral gene expression. By systematically screening each of the six VHSV structural and nonstructural genes, we identified matrix protein (M) as the virus' most potent antihost protein. Only M of VHSV genotype IV sublineage b (VHSV-IVb) suppressed mitochondrial antiviral signaling protein (MAVS) and type I IFN-induced gene expression in a dose-dependent manner. M also suppressed the constitutively active simian virus 40 (SV40) promoter and globally decreased cellular RNA levels. Chromatin immunoprecipitation (ChIP) studies illustrated that M inhibited RNA polymerase II (RNAP II) recruitment to gene promoters and decreased RNAP II C-terminal domain (CTD) Ser2 phosphorylation during VHSV infection. However, transcription directed by RNAP I to III was suppressed by M. To identify regions of functional importance, M proteins from a variety of VHSV strains were tested in cell-based transcriptional inhibition assays. M of a particular VHSV-Ia strain, F1, was significantly less potent than IVb M at inhibiting SV40/luciferase (Luc) expression yet differed by just 4 amino acids. Mutation of D62 to alanine alone, or in combination with an E181-to-alanine mutation (D62A E181A), dramatically reduced the ability of IVb M to suppress host transcription. Introducing either M D62A or D62A E181A mutations into VHSV-IVb via reverse genetics resulted in viruses that replicated efficiently but exhibited less cytotoxicity and reduced antitranscriptional activities, implicating M as a primary regulator of cytopathicity and host transcriptional suppression.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell LineChromatin ImmunoprecipitationCyprinidaeFish DiseasesHEK293 CellsHemorrhagic Septicemia, ViralHumansImmunity, InnateInterferon Type INovirhabdovirusPhosphorylationPromoter Regions, GeneticRNARNA Polymerase IIAdaptor Proteins, Signal TransducingInterferon Type IMAVS protein, humanRNARNA Polymerase IIViral Matrix Proteinsmatrix proteinMAVStranscriptional inhibitionVHSV

Identifiers

PMID28747493
PMCPMC5599748
OpenAlexW2738308417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.